DEXANTA Chewable tablet Ref.[115624] Active ingredients: Aluminium hydroxide Magnesium hydroxide Simethicone

Source: Registered Drug Product Database (NG)  Revision Year: 2023  Publisher: Applicant / Holder of Certificate of Product Registration: Glorious Dexa Mandaya Ltd., 2nd Floor NIS Building, Plot B, Block H, Elephant Cement Way, Central Business District (CBD), Ikeja, Lagos, Nigeria Manufactured by: PT Beta Pharmacon, Kawasan Industri Suryacipta, Jl. Surya Madya Kav I-18C, Karawang-Indonesia For: PT Dexa Medica, Jl. Jend. Bambang Utoyo No. 138, Palembang-Indonesia

4.1. Therapeutic indications

Symptomatic relief of hyperacidity, gastritis, gastric ulcers, and duodenal ulcers such as nausea, gastric pain, heartburn, flatulence, and fullness of the stomach.

4.2. Posology and method of administration

Adults: 1 – 2 tablets, 3 – 4 times daily.

Children 6–12 years: ½ – 1 tablet, 3 – 4 times daily.

4.9. Overdose

Large doses and prolonged use of this medicine may cause anorexia, malaise, muscle weakness, kidney stones, osteoporosis, hypotension, nausea, and vomiting. In case of overdose, get medical help or contact a physician.

6.3. Shelf life

48 months.

6.4. Special precautions for storage

Store at temperatures below 30ºC, protect from light.

6.5. Nature and contents of container

Box, 10 catch covers x 1 strip x 10 chewable tablets.

6.6. Special precautions for disposal and other handling

Not applicable.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.